American Society of Hematology, Blood, p. blood-2018-02-833582
DOI: 10.1182/blood-2018-02-833582
Full text: Unavailable
Key Points CD44 is a RAS/STAT5-dependent target in neoplastic mast cells and correlates with aggressiveness of mastocytosis. Depletion of CD44 in neoplastic mast cells is associated with reduced invasion and prolonged survival in SCID mice.